Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Quality evaluation, fatty acid analysis and untargeted profiling of volatiles in Cambodian rice.

Concepcion JCT, Ouk S, Riedel A, Calingacion M, Zhao D, Ouk M, Garson MJ, Fitzgerald MA.

Food Chem. 2018 Feb 1;240:1014-1021. doi: 10.1016/j.foodchem.2017.08.019. Epub 2017 Aug 4.


Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.

Vaisitti T, Gaudino F, Ouk S, Moscvin M, Vitale N, Serra S, Arruga F, Zakrzewski JL, Liou HC, Allan JN, Furman RR, Deaglio S.

Haematologica. 2017 Nov;102(11):1878-1889. doi: 10.3324/haematol.2017.173419. Epub 2017 Aug 31.


Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses.

Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai JJ, Smith OM, Levy ER, Kreines FM, Ziegler CG, Scallion MI, Doubrovin M, Heller G, Younes A, O'Reilly RJ, van den Brink MR, Zakrzewski JL.

Cancer Res. 2016 Jan 15;76(2):377-89. doi: 10.1158/0008-5472.CAN-14-2814. Epub 2016 Jan 7.


A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Shono Y, Tuckett AZ, Ouk S, Liou HC, Altan-Bonnet G, Tsai JJ, Oyler JE, Smith OM, West ML, Singer NV, Doubrovina E, Pankov D, Undhad CV, Murphy GF, Lezcano C, Liu C, O'Reilly RJ, van den Brink MR, Zakrzewski JL.

Cancer Discov. 2014 May;4(5):578-91. doi: 10.1158/2159-8290.CD-13-0585. Epub 2014 Feb 18.


ARN-509: a novel antiandrogen for prostate cancer treatment.

Clegg NJ, Wongvipat J, Joseph JD, Tran C, Ouk S, Dilhas A, Chen Y, Grillot K, Bischoff ED, Cai L, Aparicio A, Dorow S, Arora V, Shao G, Qian J, Zhao H, Yang G, Cao C, Sensintaffar J, Wasielewska T, Herbert MR, Bonnefous C, Darimont B, Scher HI, Smith-Jones P, Klang M, Smith ND, De Stanchina E, Wu N, Ouerfelli O, Rix PJ, Heyman RA, Jung ME, Sawyers CL, Hager JH.

Cancer Res. 2012 Mar 15;72(6):1494-503. doi: 10.1158/0008-5472.CAN-11-3948. Epub 2012 Jan 20.


6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors.

Nagasawa JY, Song J, Chen H, Kim HW, Blazel J, Ouk S, Groschel B, Borges V, Ong V, Yeh LT, Girardet JL, Vernier JM, Raney AK, Pinkerton AB.

Bioorg Med Chem Lett. 2011 Jan 15;21(2):760-3. doi: 10.1016/j.bmcl.2010.11.108. Epub 2010 Nov 30.


Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC).

Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J.

J Med Chem. 2010 Apr 8;53(7):2779-96. doi: 10.1021/jm901488g.


Direct Rel/NF-κB inhibitors: structural basis for mechanism of action.

Ouk S, Liou ML, Liou HC.

Future Med Chem. 2009 Dec;1(9):1683-707. doi: 10.4155/fmc.09.96. Review.


Development of a second-generation antiandrogen for treatment of advanced prostate cancer.

Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen CD, Higano CS, Beer TM, Hung DT, Scher HI, Jung ME, Sawyers CL.

Science. 2009 May 8;324(5928):787-90. doi: 10.1126/science.1168175. Epub 2009 Apr 9.


The use of the World Wide Web by medical journals in 2003 and 2005: an observational study.

Schriger DL, Ouk S, Altman DG.

Pediatrics. 2007 Jan;119(1):e53-60.


A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats.

Akiba Y, Jung M, Ouk S, Kaunitz JD.

Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G753-9. Epub 2005 May 19.


Interobserver agreement in emergency department triage.

Nakagawa J, Ouk S, Schwartz B, Schriger DL.

Ann Emerg Med. 2003 Feb;41(2):191-5.


The impact of a guideline-driven computer charting system on the emergency care of patients with acute low back pain.

Day F, Hoang LP, Ouk S, Nagda S, Schriger DL.

Proc Annu Symp Comput Appl Med Care. 1995:576-80.

Supplemental Content

Support Center